Clinical Trial Update: Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Shensongyangxin Capsule in treating sinus bradycardia with premature ventricular contractions; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ventricular Contractions
• Sinus Bradycardia

Drugs mentioned

• Shensongyangxin Capsule

Snippet

Sponsor: kejiang Cao | Conditions: Premature Ventricular Contraction | Phase 4 | Status: UNKNOWN